396 related articles for article (PubMed ID: 17965421)
1. Inhibitory effect of Gram-negative and Gram-positive microorganisms against Helicobacter pylori clinical isolates.
López-Brea M; Alarcón T; Domingo D; Díaz-Regañón J
J Antimicrob Chemother; 2008 Jan; 61(1):139-42. PubMed ID: 17965421
[TBL] [Abstract][Full Text] [Related]
2. In vitro activities of tigecycline combined with other antimicrobials against multiresistant gram-positive and gram-negative pathogens.
Vouillamoz J; Moreillon P; Giddey M; Entenza JM
J Antimicrob Chemother; 2008 Feb; 61(2):371-4. PubMed ID: 18033780
[TBL] [Abstract][Full Text] [Related]
3. Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: report from the SENTRY antimicrobial surveillance program (1999-2004).
Fritsche TR; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2007 May; 58(1):19-26. PubMed ID: 17383139
[TBL] [Abstract][Full Text] [Related]
4. [Antagonistic activity of Lactobacillus bacteria strains against anaerobic gastrointestinal tract pathogens (Helicobacter pylori, Campylobacter coli, Campylobacter jejuni, Clostridium difficile)].
Strus M; Pakosz K; Gościniak H; Przondo-Mordarska A; Rozynek E; Pituch H; Meisel-Mikołajczyk F; Heczko PB
Med Dosw Mikrobiol; 2001; 53(2):133-42. PubMed ID: 11757422
[TBL] [Abstract][Full Text] [Related]
5. The in-vitro antimicrobial activity of Abrus precatorius (L) fabaceae extract on some clinical pathogens.
Adelowotan O; Aibinu I; Adenipekun E; Odugbemi T
Niger Postgrad Med J; 2008 Mar; 15(1):32-7. PubMed ID: 18408781
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004-2007).
Nørskov-Lauritsen N; Marchandin H; Dowzicky MJ
Int J Antimicrob Agents; 2009 Aug; 34(2):121-30. PubMed ID: 19342205
[TBL] [Abstract][Full Text] [Related]
7. [Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005].
Yang QW; Xu YC; Chen MJ; Hu YJ; Ni YX; Sun JY; Yu YS; Kong HS; He L; Wu WY; Ye HF; Yang YM; Zhu LN; Guo SH; Ji P; Zhu ZH; Ren JK; Zhang LX; Sun ZY; Zhu XH; Tong MQ; Zhao WS; Mei YN; Liu Y; Zhang ZJ; Duan Q; Li D; Liu PP; Wang J; Han LX; Wang H; Xie XL
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2753-8. PubMed ID: 18167265
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in-vitro antibacterial activity of 5-substituted 1-methyl-4-nitro-1H-imidazoles.
Letafat B; Emami S; Aliabadi A; Mohammadhosseini N; Moshafi MH; Asadipour A; Shafiee A; Foroumadi A
Arch Pharm (Weinheim); 2008 Aug; 341(8):497-501. PubMed ID: 18618489
[TBL] [Abstract][Full Text] [Related]
9. Multicenter study to assess the in vitro activity of tigecycline by disk diffusion test against clinical isolates from Argentina.
Fernández Canigia L; Kaufman S; Lanata L; Vay C; Giovanakis M; Bantar C;
Chemotherapy; 2009; 55(1):20-7. PubMed ID: 18974645
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the in vitro activity of azlocillin and carbenicillin against 856 clinical bacterial isolates.
Skar AG; Midtvedt T; Dahl O
NIPH Ann; 1984 Jun; 7(1):13-9. PubMed ID: 6493580
[TBL] [Abstract][Full Text] [Related]
11. In vitro study to compare sensitivity of amoxicillin+clavulanic acid and cefpodoxime+clavulanic acid among beta-lactamase positive clinical isolates of gram-positive and gram-negative pathogens.
Pal RB; Pal P; Jain S; Kulkarni KP
J Indian Med Assoc; 2008 Aug; 106(8):545-8. PubMed ID: 18975519
[TBL] [Abstract][Full Text] [Related]
12. Strain-specific inhibition of Helicobacter pylori by Lactobacillus salivarius and other lactobacilli.
Ryan KA; Daly P; Li Y; Hooton C; O'Toole PW
J Antimicrob Chemother; 2008 Apr; 61(4):831-4. PubMed ID: 18263567
[TBL] [Abstract][Full Text] [Related]
13. [In vitro activity of norfloxacin against gram-positive and gram-negative organisms from recent clinical isolates].
Mancini C; Brenciaglia MI; Ghezzi MC; Giordano A; Nazzari C; Cipriani P
Boll Ist Sieroter Milan; 1985; 64(4):289-93. PubMed ID: 3935135
[TBL] [Abstract][Full Text] [Related]
14. Comparative in vitro activity of tigecycline and other antimicrobials against Gram-negative and Gram-positive organisms collected from the Asia-Pacific Rim as part of the Tigecycline Evaluation and Surveillance Trial (TEST).
Bouchillon SK; Iredell JR; Barkham T; Lee K; Dowzicky MJ
Int J Antimicrob Agents; 2009 Feb; 33(2):130-6. PubMed ID: 18995992
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial analysis in vitro of ethyl-cyanoacrylate against ocular pathogens.
de Almeida Manzano RP; Naufal SC; Hida RY; Guarnieri LO; Nishiwaki-Dantas MC
Cornea; 2006 Apr; 25(3):350-1. PubMed ID: 16633038
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a 3944 Da bacteriocin, produced by Enterococcus mundtii ST15, with activity against Gram-positive and Gram-negative bacteria.
De Kwaadsteniet M; Todorov SD; Knoetze H; Dicks LM
Int J Food Microbiol; 2005 Dec; 105(3):433-44. PubMed ID: 16102864
[TBL] [Abstract][Full Text] [Related]
17. Tigecycline in vitro activity against gram-negative and gram-positive pathogens collected in Italy.
Roveta S; Marchese A; Debbia EA
Chemotherapy; 2008; 54(1):43-9. PubMed ID: 18073470
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections.
Tsai TY; Chang SC; Hsueh PR; Feng NH; Wang JT
J Microbiol Immunol Infect; 2007 Dec; 40(6):481-6. PubMed ID: 18087627
[TBL] [Abstract][Full Text] [Related]
19. [Distribution of bacteria isolated from urine cultures in Malatya University Hospital laboratory (letter)].
Yetkin G; Kuzucu C; Güçlüer N
Mikrobiyol Bul; 2006 Oct; 40(4):445-6. PubMed ID: 17205704
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of microorganisms isolated from febrile neutropenic children with neoplastic disease].
Wojak I; Gospodarek E
Med Dosw Mikrobiol; 2004; 56(4):411-9. PubMed ID: 15959998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
